Themesothelioma News
Wednesday, March 27, 2019
Proteostasis’ CF Triple Combo Therapy Shows Potential in Phase 1 Trial
Proteostasis’ CF Triple Combo Therapy Shows Potential in Phase 1 Trial
Triple Combo of Proteostasis’ CFTR Modulators May Benefit CF Patients, Phase 1 Trial Shows
MARCH 27, 2019
BY
ALICE MELÃO
IN
CYSTIC FIBROSIS
,
NEWS
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment